← Back to Bills
HR 9382118th CongressFailed / ExpiredHouse

Alpha-gal Allergen Inclusion Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
May 27, 2025
Latest Action Date
Aug 16, 2024

Latest Action

Referred to the House Committee on Energy and Commerce.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Alpha-gal Allergen Inclusion Act (H.R. 9382) was a proposed bill introduced in the 118th Congress aimed at addressing issues related to the alpha-gal allergen. The bill was referred to the House Committee on Energy and Commerce but did not advance further and ultimately failed or expired. No official summary or full text is available, limiting detailed analysis of its provisions. The bill falls within the health policy area and likely intended to regulate or include alpha-gal allergen considerations in relevant health or consumer safety frameworks.

Bottom Line

H.R. 9382 sought to address alpha-gal allergen issues but did not progress beyond committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House during the 118th Congress and referred to the House Committee on Energy and Commerce.
  • No official summary or full text is publicly available, restricting detailed content analysis.
  • The bill is categorized under the health policy area and relates to the alpha-gal allergen.
Who Benefits?

['Individuals affected by alpha-gal allergy', 'Health agencies involved in allergen regulation', 'Healthcare providers managing allergen-related conditions']

Potential Concerns

['Lack of publicly available full text limits understanding of implementation requirements and enforcement mechanisms.', 'Unclear funding sources or budgetary impacts due to missing financial details.', 'No information on oversight or authority changes related to allergen regulation.']

Political Context

The bill was introduced and referred to a relevant committee but did not advance, reflecting limited legislative movement. The referral to the House Committee on Energy and Commerce aligns with the committee's jurisdiction over health-related matters. The bill's failure or expiration indicates it did not receive sufficient legislative support or priority during the session.

Hidden Impact Review

High concern review — 3 hidden impact flags detected

GovScope reviewed 3 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

High Concern
Detected Flags
Indirect Effects

['Potential increased awareness and regulation of alpha-gal allergen if enacted.', 'Possible impacts on healthcare protocols and allergen labeling standards.', 'Could influence research and public health initiatives related to allergen management.']

GovScope Watchdog Notes

The absence of both the full bill text and an official summary significantly limits transparency and public understanding of H.R. 9382. This lack of information hinders comprehensive oversight and evaluation of the bill's potential impacts, costs, and enforcement mechanisms. The bill's failure to progress beyond committee referral further reduces available data on legislative intent and stakeholder engagement.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready